Article
Distinct metabolic phenotype renders β-catenin mutant hepatocellular carcinoma susceptible to treatment-induced ischemia
2023-09-29
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background & Aims</h4> Transarterial chemoembolization (TACE) is the most common treatment for hepatocellular carcinoma (HCC) worldwide; however, response rates and durability vary widely. With the growing armamentarium of therapies for HCC patients, identifying predictors of response to TACE has become increasingly important for a patient population with limited hepatic reserve. We hypothesi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 11cad0a9-44ad-5870-a41b-3af5d7e168e8
- DOI
- 10.1101/2023.09.28.23296283
